Switch to:
Alexion Pharmaceuticals Inc (NAS:ALXN)
Piotroski F-Score
8 (As of Today)

Good Sign:

Piotroski F-Score of 8 is 8, indicating very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Alexion Pharmaceuticals Inc has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

ALXN' s 10-Year Piotroski F-Score Range
Min: 1   Max: 8
Current: 8

1
8

During the past 13 years, the highest Piotroski F-Score of Alexion Pharmaceuticals Inc was 8. The lowest was 1. And the median was 4.


Definition

How is the Piotroski F-Score calculated?

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

This Year (Sep14) TTM:Last Year (Sep13) TTM:
Net Income was -18.992 + 159.354 + 166.495 + 177.731 = $485 Mil.
Cash Flow from Operations was 208.881 + -31.055 + 106.15 + 281.521 = $565 Mil.
Revenue was 441.909 + 566.616 + 512.495 + 555.146 = $2,076 Mil.
Gross Profit was 390.357 + 533.677 + 472.869 + 503.288 = $1,900 Mil.
Average Total Assets from the begining of this year (Sep13)
to the end of this year (Sep14) was
(3049.795 + 3317.696 + 3379.666 + 3553.81 + 3890.887) / 5 = $3438.3708 Mil.
Total Assets at the begining of this year (Sep13) was $3,050 Mil.
Long-Term Debt was $109 Mil.
Total Current Assets was $2,560 Mil.
Total Current Liabilities was $503 Mil.
Net Income was 80.971 + 82.217 + 95.885 + 93.785 = $353 Mil.

Revenue was 320.526 + 338.941 + 370.091 + 400.405 = $1,430 Mil.
Gross Profit was 287.379 + 303.672 + 330.714 + 349.047 = $1,271 Mil.
Average Total Assets from the begining of last year (Sep12)
to the end of last year (Sep13) was
(2505.608 + 2613.56 + 2685.881 + 2815.238 + 3049.795) / 5 = $2734.0164 Mil.
Total Assets at the begining of last year (Sep12) was $2,506 Mil.
Long-Term Debt was $89 Mil.
Total Current Assets was $1,916 Mil.
Total Current Liabilities was $395 Mil.

Profitability

Q1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by total assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Alexion Pharmaceuticals Inc's current net income (TTM) was 485. ==> Positive ==> Score 1.

Q2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by total assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Alexion Pharmaceuticals Inc's current cash flow from operations (TTM) was 565. ==> Positive ==> Score 1.

Q3. Change in Return on Assets

Compare this year’s return on assets (1) to last year’s return on assets.

Score 1 if it’s higher, 0 if it’s lower.

ROA (This Year)=Net Income (TTM)/Total Assets at the Beginning of This Year (Sep13)
=484.588/3049.795
=0.15889199

ROA (Last Year)=Net Income (TTM)/Total Assets at the Beginning of Last Year (Sep12)
=352.858/2505.608
=0.1408273

Alexion Pharmaceuticals Inc's return on assets of this year was 0.15889199. Alexion Pharmaceuticals Inc's return on assets of last year was 0.1408273. ==> This year is higher. ==> Score 1.

Q4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Alexion Pharmaceuticals Inc's current net income (TTM) was 485. Alexion Pharmaceuticals Inc's current cash flow from operations (TTM) was 565. ==> 565 > 485 ==> CFROA > ROA ==> Score 1.

Funding

Q5. Change in Gearing or Leverage

Compare this year’s gearing (long-term debt divided by average total assets) to last year’s gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep14)=Long-Term Debt/Average Total Assets from Sep13 to Sep14
=108.53/3438.3708
=0.03156437

Gearing (Last Year: Sep13)=Long-Term Debt/Average Total Assets from Sep12 to Sep13
=89.251/2734.0164
=0.03264465

Alexion Pharmaceuticals Inc's gearing of this year was 0.03156437. Alexion Pharmaceuticals Inc's gearing of last year was 0.03264465. ==> This year is lower or equal to last year. ==> Score 1.

Q6. Change in Working Capital (Liquidity)

Compare this year’s current ratio (current assets divided by current liabilities) to last year’s current ratio.

Score 1 if this year'’s current ratio is higher, 0 if it’s lower

Current Ratio (This Year: Sep14)=Total Current Assets/Total Current Liabilities
=2559.878/502.537
=5.0939095

Current Ratio (Last Year: Sep13)=Total Current Assets/Total Current Liabilities
=1915.502/395.456
=4.84378034

Alexion Pharmaceuticals Inc's current ratio of this year was 5.0939095. Alexion Pharmaceuticals Inc's current ratio of last year was 4.84378034. ==> This year's current ratio is higher. ==> Score 1.

Q7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Alexion Pharmaceuticals Inc's number of shares in issue this year was 201.3. Alexion Pharmaceuticals Inc's number of shares in issue last year was 199.7. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Q8. Change in Gross Margin

Compare this year’s gross margin (gross profit divided by sales) to last year’s.

Score 1 if this year’s gross margin is higher, 0 if it’s lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1900.191/2076.166
=0.9152404

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1270.812/1429.963
=0.88870271

Alexion Pharmaceuticals Inc's gross margin of this year was 0.9152404. Alexion Pharmaceuticals Inc's gross margin of last year was 0.88870271. ==> This year's gross margin is higher. ==> Score 1.

Q9. Change in asset turnover

Compare this year’s asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year’s asset turnover ratio.

Score 1 if this year’s asset turnover ratio is higher, 0 if it’s lower

Asset Turnover (This Year)=Revenue (TTM)/Total Assets at the Beginning of This Year (Sep13)
=2076.166/3049.795
=0.68075592

Asset Turnover (Last Year)=Revenue (TTM)/Total Assets at the Beginning of Last Year (Sep12)
=1429.963/2505.608
=0.57070499

Alexion Pharmaceuticals Inc's asset turnover of this year was 0.68075592. Alexion Pharmaceuticals Inc's asset turnover of last year was 0.57070499. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score=Q1+Q2+Q3+Q4+Q5+Q6+Q7+Q8+Q9
=1+1+1+1+1+1+0+1+1
=8

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Alexion Pharmaceuticals Inc has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.


Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Related Terms

Net Income, Cash Flow from Operations, Revenue, Gross Profit, Total Assets, Long-Term Debt, Total Current Assets, Total Current Liabilities


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Alexion Pharmaceuticals Inc Annual Data

Jul04Jul05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Q1 0000111111
Q2 0000111111
Q3 0001110110
Q4 1110101111
Q5 0001111101
Q6 1010011010
Q7 0000000000
Q8 0000000110
Q9 1011110110
F-score 3133665774

Alexion Pharmaceuticals Inc Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
Q1 1111111111
Q2 1111111111
Q3 1110000001
Q4 1111111111
Q5 0001111111
Q6 0111110111
Q7 0000010000
Q8 1111100001
Q9 1110000111
F-score 6776664668
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK